Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment

Abstract Biliary tract cancers are rare cancers with poor prognosis due to a lack of therapeutic options, especially after the failure of first-line systemic treatment. Targeted treatments for this clinical situation are promising and have entered clinical practice. We aimed to describe the overall...

Full description

Bibliographic Details
Main Authors: Bernhard Doleschal, Hossein Taghizadeh, Gerald Webersinke, Gudrun Piringer, Georg Schreil, Jörn Decker, Karl J. Aichberger, Patrick Kirchweger, Josef Thaler, Andreas Petzer, Clemens A. Schmitt, Gerald W. Prager, Holger Rumpold
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-42083-4